Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 10.11.2021.

Biotechnology
Medicine
Mutual fund
Finance
Therapy
Vaccination

Startups

@Forbes shared
On Nov 8, 2021
Another approach that could prevent Covid may soon be an option in India https://t.co/QvWyiaaV5c
Open
This Company Has Applied For Authorization In India For Its Nasal Spray That Prevents Covid

This Company Has Applied For Authorization In India For Its Nasal Spray That Prevents Covid

Ireland-based pHOXBIO’s medicine was shown to provide protection against Covid in clinical trials.

@FlagshipPioneer shared
On Nov 9, 2021
RT @FierceBiotech: "We can literally use one single tRNA medicine to treat thousands of diseases," said founding CEO Lovisa Afzelius, Ph.D., in an interview with Fierce Biotech https://t.co/syIAs27fqy
Open
Flagship unveils its next RNA bet with $50M for Alltrna to explore thousands of genetic diseases using transfer RNA

Flagship unveils its next RNA bet with $50M for Alltrna to explore thousands of genetic diseases using transfer RNA

Flagship helped lead the way in messenger RNA by incubating Moderna. Now, the biotech founder wants to revolutionize transfer RNAs with $50 million dedicated to Flagship's newest venture, ...

@BosBizDon shared
On Nov 3, 2021
After seeing 380 biotechs come through their labs, this team raised $275 million to fix gaps in the startup ecosystem https://t.co/8ycIrqAYf9
Open
After seeing 380 biotechs come through their labs, this team raised $275 million to fix gaps in the startup ecosystem

After seeing 380 biotechs come through their labs, this team raised $275 million to fix gaps in the startup ecosystem

The team at Mission BioCapital operates a dozen successful labs across the US, giving them a view into the gaps in biotech venture capital.

@BusinessInsider shared
On Nov 10, 2021
SoftBank is betting big on healthcare in its second fund. Here are the 12 startups its backed in the last 10 months. https://t.co/m6CYboCaqH
Open
SoftBank is betting big on healthcare in its second fund. Here are the 12 startups its backed in the last 10 months.

SoftBank is betting big on healthcare in its second fund. Here are the 12 startups its backed in the last 10 months.

SoftBank has participated in $6.2 billion worth of funding rounds for healthcare companies so far in 2021.

@FierceBiotech shared
On Nov 5, 2021
GlycoEra's origins are enough to make your head spin. The biotech spun off from LimmaTech, which itself spun out of a GlaxoSmithKline specialist vaccines unit known as GlycoVaxyn. https://t.co/1T3T8ojyg7
Open
Veterans from GSK's GlycoVaxyn rally up $49M to advance Swiss biotech GlycoEra

Veterans from GSK's GlycoVaxyn rally up $49M to advance Swiss biotech GlycoEra

Veronica Gambillara Fonck, Ph.D., has been one member of a group of scientists that have followed each other across a dizzying landscape of spinoffs and new ventures in vaccines R&D. Now, ...

@FierceBiotech shared
On Nov 4, 2021
The investor will work with academic researchers and entrepreneurs to launch companies with new technology, the firm said https://t.co/0WpYeAEZqu
Open
VC shop Mission BioCapital raises $275M 5th fund with focus on incubating startups

VC shop Mission BioCapital raises $275M 5th fund with focus on incubating startups

Mission BioCapital pooled together $275 million for its fifth fund, which has already gone toward seven companies and is dedicated to incubating new biotechs and other life sciences ...

@BentheFidler shared
On Nov 8, 2021
Blackstone continues #biotech push with up to $250M cell therapy investment https://t.co/TO7aCLYwKu $AUTL + 27% $NVS $GILD $BMY
Open
Blackstone continues biotech push with up to $250M cell therapy investment

Blackstone continues biotech push with up to $250M cell therapy investment

The investment in CAR-T maker Autolus Therapeutics adds to a string of biotech deals the private equity firm has made since 2018.

@FierceBiotech shared
On Nov 8, 2021
Sanofi coughs up $40 million now—at a premium to Gyroscope’s prior series C financing—and is on the hook for another $20 million based on “a future qualifying investment round and subject to the satisfaction of certain closing conditions.” https://t.co/diQ8I4W5T0
Open
Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt

Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt

The biotech IPO window, at the start of the year at least, was wide open, leaving more than a few people scratching their heads when the eye disease biotech said back in May it was ditching ...

Read more: Startups
weekly 10.11.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy